Sanford Cosponsors Two Right To Try Bills
WASHINGTON, DC - Representative Mark Sanford has signed on as a cosponsor of H.R. 878, the Right to Try Act, which would grant terminally-ill patients access to drugs that have already passed the Food and Drug Administration’s (FDA) basic safety testing but haven’t yet received final approval. This legislation was introduced in the House by Rep. Andy Biggs (R-AZ), and there are currently 86 cosponsors. The Senate passed its version of this bill in August of last year.
Rep. Sanford released the following statement:
“Removing a barrier to potentially life-saving treatment when there are no other options seems like an obvious and simple step in giving terminally ill patients every opportunity to live. In that vein, the federal government should not be standing in the way of these treatments when all other paths have been exhausted.
“With the FDA’s drug approval process taking oftentimes over ten years, some people simply don’t have the time to wait. They should be able to take advantage of innovative options that offer hope both of improving their quality of life and possibly of life itself. Accordingly, I’m proud to be a cosponsor of the Right to Try Act.”
Right to try legislation has passed in thirty-eight states, including South Carolina. Rep. Biggs’ bill would simply allow these states to override federal law prohibiting access to potentially life-saving medicine to those with terminal illnesses. This is the second right to try piece of legislation that Rep. Sanford has signed on to this Congress. The other bill was introduced by Rep. Brian Fitzpatrick (R-PA), H.R. 2368, the Right to Try Act.